Tel:
Email:

Zodasiran

Catalog number: BRP-02905

Zodasiran

Zodasiran is an RNA interference (RNAi) therapeutic that inhibits ANGPTL3 expression and reduces atherogenic lipoproteins through mechanisms independent of the LDL receptor (LDLR). It is a promising therapy for hyperlipidemia, familial hypercholesterolemia or moderate-to-severe hypertriglyceridemia.

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Catalog
BRP-02905

Chemical Structure:


Our Products

Online Inquiry
Verification code
Inquiry Basket
Loading ......
Go to checkout